Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)
Trial Parameters
Brief Summary
The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.
Eligibility Criteria
Inclusion Criteria: * diagnosed with cancer * have used any type of cannabis/marijuana, including those with cannabidiol (CBD) and/or tetrahydrocannabinol (THC) to treat their cancer * believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker Exclusion Criteria: * does not have cancer * has not used any type of cannabis/marijuana, including those with CBD and/or THC to treat their cancer * does not believe that cannabis has either stopped the tumor from growing and/or caused a cancer antigen blood marker to remain stable or cannabis has shrunken the tumor and/or caused reduction in a cancer antigen blood marker